The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Novartis AG

NYSE: NVS
Last

(U.S.) $98.61

Today's change-2.70 -2.67%
Updated March 31 4:04 PM EDT. Delayed by at least 15 minutes.
 

Novartis AG

NYSE: NVS
Last

(U.S.) $98.61

Today's change-2.70 -2.67%
Updated March 31 4:04 PM EDT. Delayed by at least 15 minutes.

Novartis AG crosses below 50-day moving average

Novartis AG closed sharply lower Tuesday, dropping (U.S.)$2.70 or 2.67% to (U.S.)$98.61 and crossing below its 50-day moving average. Shares have lost 3.22% over the last five days, but sit 4.72% below their 52-week high. This security has outperformed the S&P 500 by 5.54% during the last year.

Key company metrics

  • Open(U.S.) $98.82
  • Previous close(U.S.) $101.31
  • High(U.S.) $99.70
  • Low(U.S.) $98.61
  • Bid / Ask(U.S.) $95.00 / (U.S.) $103.00
  • YTD % change+6.42%
  • Volume1,764,448
  • Average volume (10-day)1,422,401
  • Average volume (1-month)1,528,199
  • Average volume (3-month)2,065,334
  • 52-week range(U.S.) $82.27 to (U.S.) $103.50
  • Beta0.51
  • Trailing P/E22.79×
  • P/E 1 year forward19.44×
  • Forward PEG2.37×
  • Indicated annual dividend(U.S.) $2.76
  • Dividend yield2.80%
  • Trailing EPS(U.S.) $4.33
Updated March 31 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+20.00%

Based on its net profit margin of 20.00%, Novartis AG is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue13,35413,30013,94913,031
Total other revenue--------
Total revenue13,35413,30013,94913,031
Gross profit8,9388,8799,5718,901
Total cost of revenue4,4164,4214,3784,130
Total operating expense11,00310,56110,76510,216
Selling / general / administrative3,9653,5653,8263,637
Research & development2,5372,1612,1782,210
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total85414383239
Operating income2,3512,7393,1842,815
Interest income (expense), net non-operating-188-182-166-168
Gain (loss) on sale of assets--------
Other--------
Income before tax2,7563,5323,1472,837
Income after tax2,4483,1022,7232,454
Income tax, total308430424383
Net income1,4913,2232,5552,941
Total adjustments to net income--------
Net income before extra. items2,4523,0852,6932,427
Minority interest4-17-30-27
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,4523,0852,6932,427
Inc. avail. to common incl. extra. items1,4913,2232,5552,941
Diluted net income1,4913,2232,5552,941
Dilution adjustment0000
Diluted weighted average shares2,4582,4602,4712,474
Diluted EPS excluding extraordinary itemsvalue per share1.001.251.090.98
Dividends per sharevalue per share2.760.000.000.00
Diluted normalized EPSvalue per share1.061.361.320.85